RPL36A, ribosomal protein L36a, 6173

N. diseases: 46; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.050 Biomarker disease BEFREE Transgenic mice with Mig-6 ablation in the uterus develop endometrial hyperplasia and E2-dependent endometrial cancer. 27910070 2017
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.050 Biomarker disease BEFREE The silencing of MIG6 using siRNA eliminated the P4-mediated reduction of EC cell viability, indicating that MIG6 is an essential downstream component of PR-mediated growth suppression. 28516379 2017
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.050 AlteredExpression disease BEFREE In this study, after confirming the downregulation of Mig-6 protein in endometrial carcinoma (EC) tissues, the expression of Mig-6 was upregulated in Ishikawa cells by pCMV6-Mig-6 plasmid. 26450625 2015
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.050 Biomarker disease BEFREE In this study, we show that MIG-6 also acts as a tumor suppressor in endometrial cancers associated with PTEN deficiency. 25377472 2014
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.050 AlteredExpression disease BEFREE Importantly, the observation that endometrial carcinomas from women have a significant reduction in MIG-6 expression provides compelling support for an important growth regulatory role for Mig-6 in the uterus of both humans and mice. 19439667 2009